Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000885947 | SCV001029428 | likely benign | not provided | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000885947 | SCV005227115 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001273033 | SCV001455569 | likely benign | Hermansky-Pudlak syndrome | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003895429 | SCV004708869 | likely benign | HPS1-related disorder | 2023-11-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |